384 related articles for article (PubMed ID: 37583933)
21. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.
Ahangar Davoodi N; Najafi S; Naderi Ghale-Noie Z; Piranviseh A; Mollazadeh S; Ahmadi Asouri S; Asemi Z; Morshedi M; Tamehri Zadeh SS; Hamblin MR; Sheida A; Mirzaei H
Front Cell Dev Biol; 2022; 10():1065837. PubMed ID: 36619866
[TBL] [Abstract][Full Text] [Related]
22. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs.
Li Y; Al Hallak MN; Philip PA; Azmi AS; Mohammad RM
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439315
[TBL] [Abstract][Full Text] [Related]
23. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.
Wang W; Hao LP; Song H; Chu XY; Wang R
Front Oncol; 2022; 12():790916. PubMed ID: 35280805
[TBL] [Abstract][Full Text] [Related]
24. The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer.
Yue Y; Lin X; Qiu X; Yang L; Wang R
Front Cell Dev Biol; 2021; 9():802745. PubMed ID: 34966746
[TBL] [Abstract][Full Text] [Related]
25. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.
Mousavi SM; Derakhshan M; Baharloii F; Dashti F; Mirazimi SMA; Mahjoubin-Tehran M; Hosseindoost S; Goleij P; Rahimian N; Hamblin MR; Mirzaei H
Mol Ther Oncolytics; 2022 Mar; 24():262-287. PubMed ID: 35071748
[TBL] [Abstract][Full Text] [Related]
26. Roles of Non-Coding RNAs in Cervical Cancer Metastasis.
Cheng T; Huang S
Front Oncol; 2021; 11():646192. PubMed ID: 33777808
[TBL] [Abstract][Full Text] [Related]
27. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
Feng Q; Zhang H; Yao D; Chen WD; Wang YD
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
[TBL] [Abstract][Full Text] [Related]
28. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications.
Bravo-Vázquez LA; Frías-Reid N; Ramos-Delgado AG; Osorio-Pérez SM; Zlotnik-Chávez HR; Pathak S; Banerjee A; Bandyopadhyay A; Duttaroy AK; Paul S
Transl Oncol; 2023 Jan; 27():101579. PubMed ID: 36332600
[TBL] [Abstract][Full Text] [Related]
30. Roles of Non-coding RNAs and Angiogenesis in Glioblastoma.
Balandeh E; Mohammadshafie K; Mahmoudi Y; Hossein Pourhanifeh M; Rajabi A; Bahabadi ZR; Mohammadi AH; Rahimian N; Hamblin MR; Mirzaei H
Front Cell Dev Biol; 2021; 9():716462. PubMed ID: 34646821
[TBL] [Abstract][Full Text] [Related]
31. Non-coding RNAs, another side of immune regulation during triple-negative breast cancer.
Alghazali MW; Al-Hetty HRAK; Ali ZMM; Saleh MM; Suleiman AA; Jalil AT
Pathol Res Pract; 2022 Nov; 239():154132. PubMed ID: 36183439
[TBL] [Abstract][Full Text] [Related]
32. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.
Khanbabaei H; Ebrahimi S; García-Rodríguez JL; Ghasemi Z; Pourghadamyari H; Mohammadi M; Kristensen LS
J Exp Clin Cancer Res; 2022 Sep; 41(1):278. PubMed ID: 36114510
[TBL] [Abstract][Full Text] [Related]
33. Non-coding RNA dysregulation in skin cancers.
Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
[TBL] [Abstract][Full Text] [Related]
34. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
35. Role of MicroRNAs and Long Non-Coding RNAs in Regulating Angiogenesis in Human Breast Cancer: A Molecular Medicine Perspective.
Golhani V; Ray SK; Mukherjee S
Curr Mol Med; 2022; 22(10):882-893. PubMed ID: 34923940
[TBL] [Abstract][Full Text] [Related]
36. Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway.
Bu T; Li L; Tian J
Front Pharmacol; 2023; 14():1269233. PubMed ID: 37829301
[TBL] [Abstract][Full Text] [Related]
37. The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer.
Kapinova A; Kubatka P; Zubor P; Golubnitschaja O; Dankova Z; Uramova S; Pilchova I; Caprnda M; Opatrilova R; Richnavsky J; Kruzliak P; Danko J
Biomed Pharmacother; 2018 Mar; 99():51-58. PubMed ID: 29324312
[TBL] [Abstract][Full Text] [Related]
38. Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.
Treeck O; Haerteis S; Ortmann O
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980520
[TBL] [Abstract][Full Text] [Related]
39. Non-Coding RNAs and Endometrial Cancer.
Vallone C; Rigon G; Gulia C; Baffa A; Votino R; Morosetti G; Zaami S; Briganti V; Catania F; Gaffi M; Nucciotti R; Costantini FM; Piergentili R; Putignani L; Signore F
Genes (Basel); 2018 Mar; 9(4):. PubMed ID: 29596364
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers.
Zhan H; Tu S; Zhang F; Shao A; Lin J
Front Cell Dev Biol; 2020; 8():145. PubMed ID: 32219093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
